The American Academy of Dermatology (AAD) meeting last week continued to provide positive news, including from US biotech ...

US biotech Regenxbio (Nasdaq: RGNX) has successfully completed the BLA submission for its mucopolysaccharidosis II (MPS II) ...

Japanese drugmaker Ono (TYO: 4528) has entered into a license agreement with USA-based Ionis Pharmaceuticals (Nasdaq: IONS) ...

Chinese pharmaceutical company Fosun Pharmaceutical Group (SHA: 600196) has agreed to sell its stake in private hospital ...

The UK government plans to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% of subject ...

The UK has announced plans to abolish NHS England and integrate its functions into the central government, marking a ...

The US Food and Drug Administration (FDA) has announced its recommendations to vaccine manufacturers for the virus strains to ...

Innovent Biologics (HKEX: 01801) has gained approval in China for Sycume (teprotumumab), the country’s first IGF-1R antibody ...

USA-based Azurity Pharmaceuticals says it has completed its acquisition of Covis Group from existing investors and the ...

Sutro Biopharma (Nasdaq: STRO), a US biotechnology company, has announced significant organizational changes, including a ...

Japanese drugmaker Seikagaku Corporation (TYO: 4548) announced that it has received a complete response letter (CRL) from the ...

Guaranteed success in drug development does not exist, such are the inherent risks, potential pitfalls and costs involved.